EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Preference of young adults for COVID-19 vaccination in the United Kingdom: a discrete choice experiment

Sophie Böger, Ilja van Bergen, Charlotte Beaudart iD, Kei Long Cheung iD, Mickaël Hiligsmann iD

Expert Review of Pharmacoeconomics & Outcomes Research · 2023

DOI: 10.1080/14737167.2023.2223983 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Expert Review of Pharmacoeconomics & Outcomes Research, 2023. Verfasst von Sophie Böger und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands. Hauptthemen laut MEDLINE: COVID-19, Vaccines. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To determine preferences for COVID-19 vaccinations in the young adult population in the United Kingdom (UK). METHOD: A discrete choice experiment survey was conducted in UK young adults. Participants were asked to choose between two hypothetical vaccines the one they preferred the most. Vaccines were defined by five attributes (effectiveness, risk of side effects, duration of protection, number of doses, confidence in available evidence), identified following a systematic literature review and qualitative interviews with 13 young adults. A random parameters logit model, a latent class model, and subgroup analyses were used to identify preferences. RESULTS: One hundred and forty-nine respondents were included (70% women, mean age 23 years). All five attributes significantly influenced respondents' vaccination decisions. Respondents valued higher effectiveness, lower risk of side effects, longer protection duration, and a smaller number of doses. Based on the range of levels of each attribute, vaccine effectiveness was the most important attribute (relative importance 34%), followed by risk of side effects (32%), and duration of vaccine protection (22%). CONCLUSIONS: The five investigated vaccine attributes appear to play an important role in young adults' decision-making process. Results of this study may help health authorities designing appropriate strategies in future vaccines campaigns in the younger UK population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19VaccinesAdultFemaleHumansMaleYoung AdultChoice BehaviorCOVID-19 VaccinesPatient PreferenceSurveys and QuestionnairesUnited KingdomVaccination

Stichwörter der Autor:innen

COVID-19Discrete Choice ExperimentHealth policyPreferenceVaccine

Substanzen

COVID-19 VaccinesVaccines

Autor:innen und Institutionen

  • Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.
  • Department of Health Sciences, College of Health Medicine and Life Sciences, Brunel University London, London, UK.
  • Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands.

ORCID-Profile: Charlotte Beaudart, Kei Long Cheung, Mickaël Hiligsmann

Zitieren

APA

Böger, S., van Bergen, I., Beaudart, C., Cheung, K. L., & Hiligsmann, M. (2023). Preference of young adults for COVID-19 vaccination in the United Kingdom: a discrete choice experiment. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2023.2223983

Vancouver

Böger S, van Bergen I, Beaudart C, Cheung KL, Hiligsmann M. Preference of young adults for COVID-19 vaccination in the United Kingdom: a discrete choice experiment. Expert Review of Pharmacoeconomics & Outcomes Research. 2023. doi:10.1080/14737167.2023.2223983

BibTeX
@article{Bger2023,
  author = {Böger, Sophie and van Bergen, Ilja and Beaudart, Charlotte and Cheung, Kei Long and Hiligsmann, Mickaël},
  title = {Preference of young adults for COVID-19 vaccination in the United Kingdom: a discrete choice experiment},
  journal = {Expert Review of Pharmacoeconomics & Outcomes Research},
  year = {2023},
  doi = {10.1080/14737167.2023.2223983}
}
Kostenlos starten →